EoE: Chronic, Progressive, Type 2 Inflammatory Disease
Burden Of Disease
Learn about the key drivers of type 2 inflammation in EoE and how it mediates the progressive esophageal remodeling associated with significant patient burden in this disease.
MAT-US-2101723 V2 Expiration Date 05/10/2023
Please rotate you device for optimal viewing
ADVENT is a medical education program by Sanofi Genzyme and Regeneron. This website is intended only for health care professionals in the US only.
ADVENT is a global medical education program by Sanofi Genzyme and Regeneron and is only intended for healthcare providers.
Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.
Would you like to receive updates on new ADVENT content, courses and events when available?
MAT-US-2104233 Exp 04/26/2023
Congratulations, you are now subscribed successfully.
You will receive a confirmation email at the address you provided.
If you don’t receive it, please check your spam.